BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Hypothalamus, Alcohol, Doxorubicin, rs2300478, SNCA, cell-cell adhesion, Arthritis)
Bookmark Forward

QuickView for gp160 (gene)


Body Atlas

Most Correlated Tissues

  1. Ileum mucosa
  2. Kidney cortex
  3. Small intestine
  4. Kidney medulla
  5. Kidney
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. 11p partial monosomy syndrome
  2. Disorder of iron metabolism
  3. Injury of integument
  4. Deficiency state
  5. Barrett's esophagus
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. iopromide
  2. Foscarnet
  3. enzastaurin
  4. TACSTD1 protein, human
  5. naphthalene
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. SV40_Large_T_and_small_t_Ag_common-S
  2. LRPPRC
  3. PRKDC
  4. CDX1
  5. NDRG1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Aminopeptidase A (ENPEP) gene polymorphisms and preeclampsia: Descriptive analysis.
  2. Iron deficiency downregulates ENPEP to promote angiogenesis in liver tumors.
  3. ENPEP as a potential predictor of immune checkpoint inhibitor efficacy.
  4. Expression of the COVID-19 receptor ACE2 in the human conjunctiva.
  5. Long non-coding RNA NCK1-AS1 functions as a ceRNA to regulate cell viability and invasion in esophag…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope …
  2. A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope …
  3. Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: …
  4. A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and…
  5. A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombin…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.